Terms: = Head and neck cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
203 results:
1. Tumor-associated macrophage-derived exosomal miR21-5p promotes tumor angiogenesis by regulating YAP1/HIF-1α axis in head and neck squamous cell carcinoma.
Yan Q; Liu J; Liu Y; Wen Z; Jin D; Wang F; Gao L
Cell Mol Life Sci; 2024 Apr; 81(1):179. PubMed ID: 38602536
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Domański P; Piętak M; Staneta S; Fortuniak W; Kruczyk B; Kobiernik A; Bakuła P; Mydlak A; Demkow T; Sikora-Kupis B; Dumnicka P; Kucharz J
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541124
[No Abstract] [Full Text] [Related]
3. Tumor hypoxia and role of hypoxia-inducible factor in oral cancer.
Singh P; Rajput M; Pandey M
World J Surg Oncol; 2024 Jan; 22(1):18. PubMed ID: 38200568
[TBL] [Abstract] [Full Text] [Related]
4. Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.
Daniels AB; Chang EY; Chew EY; Gombos DS; Gorin MB; Shields CL; Wiley HE
Ophthalmology; 2024 May; 131(5):622-633. PubMed ID: 38092079
[TBL] [Abstract] [Full Text] [Related]
5. Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation.
Zhang T; Xu D; Liu J; Wang M; Duan LJ; Liu M; Meng H; Zhuang Y; Wang H; Wang Y; Lv M; Zhang Z; Hu J; Shi L; Guo R; Xie X; Liu H; Erickson E; Wang Y; Yu W; Dang F; Guan D; Jiang C; Dai X; Inuzuka H; Yan P; Wang J; Babuta M; Lian G; Tu Z; Miao J; Szabo G; Fong GH; Karnoub AE; Lee YR; Pan L; Kaelin WG; Yuan J; Wei W
Nat Cell Biol; 2023 Jul; 25(7):950-962. PubMed ID: 37400498
[TBL] [Abstract] [Full Text] [Related]
6. Endolymphatic sac tumour - a rare complication associated with von Hippel-Lindau disease.
Wozniaková M; Židlík V; Škarda J
Cesk Patol; 2023; 59(1):32-35. PubMed ID: 37072278
[TBL] [Abstract] [Full Text] [Related]
7. Personalized Systemic Therapies in Hereditary cancer Syndromes.
Mastrodomenico L; Piombino C; Riccò B; Barbieri E; Venturelli M; Piacentini F; Dominici M; Cortesi L; Toss A
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980956
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing vhl through a non-canonical function of EZH2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
9. Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing.
Freeman T; Taneja C; Ohori NP; Wald AI; Skaugen J; Yip L; Kim S; Ferris RL; Nikiforova MN; Roy S; Nikiforov YE
Endocr Relat Cancer; 2022 Dec; 29(12):657-664. PubMed ID: 36205930
[TBL] [Abstract] [Full Text] [Related]
10. A Von Hippel-Lindau Disease-Associated Microcystic Adenoma of the Ethmoid Sinus Mimicking Metastatic Clear Cell Renal Cell Carcinoma.
Tsukamoto S; Koyasu S; Sugimoto A; Matsunaga M; Nakamoto Y
Clin Nucl Med; 2023 Feb; 48(2):194-196. PubMed ID: 36179325
[TBL] [Abstract] [Full Text] [Related]
11. vhl tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma.
Todorović L; Stanojević B
Biomol Biomed; 2023 Feb; 23(1):26-36. PubMed ID: 36036061
[TBL] [Abstract] [Full Text] [Related]
12. Symptoms and clinical features in patients affected by endolymphatic sac tumor: a systematic review and meta-analysis.
Gioacchini FM; Kaleci S; Chiarella G; Viola P; Pisani D; Scarpa A; Tulli M; Pace A; Iannella G; Re M
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5081-5088. PubMed ID: 35704074
[TBL] [Abstract] [Full Text] [Related]
13. A Positive Feedback Loop between Inactive vhl-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression.
Yang J; Luo L; Zhao C; Li X; Wang Z; Zeng Z; Yang X; Zheng X; Jie H; Kang L; Li S; Liu S; Zhou C; Liu H
Int J Biol Sci; 2022; 18(8):3470-3483. PubMed ID: 35637958
[TBL] [Abstract] [Full Text] [Related]
14. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
Park HS; Lee YH; Hong N; Won D; Rhee Y
Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
[TBL] [Abstract] [Full Text] [Related]
15. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of vhl protein expression promotes the progression of clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang Z; Zhang K; Xu Y; Li L; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2583-2596. PubMed ID: 35414787
[No Abstract] [Full Text] [Related]
16. Clinicopathological and Molecular Features of Secondary cancer (Metastasis) to the Thyroid and Advances in Management.
Nguyen M; He G; Lam AK
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328664
[TBL] [Abstract] [Full Text] [Related]
17. [Expression of vhl, VEGF and HIF-1α in endolymphatic sac tumors].
Mao ML; Zhao YH; Ma DL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1228-1233. PubMed ID: 34719159
[No Abstract] [Full Text] [Related]
18. [Endocrine and neuroendocrine tumors].
Riss P; Scheuba K; Strobel O
Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
[TBL] [Abstract] [Full Text] [Related]
19. Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature.
Talukdar R; Epari S; Sahay A; Choudhari A; Dasgupta A; Chatterjee A; Gupta T
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2591-2598. PubMed ID: 34410472
[TBL] [Abstract] [Full Text] [Related]
20. The Association of the BRAF-V600E Mutation with the Expression of the Molecular Markers in the Primary Tumor and Metastatic Tissue in Papillary Thyroid cancer.
Spirina LV; Chizhevskaya SY; Kovaleva IV; Kondakova IV
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2017-2024. PubMed ID: 34319022
[TBL] [Abstract] [Full Text] [Related]
[Next]
